Anne Oriordan serves as Executive at Jazz Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Anne Oriordan has executed 14 insider transactions totaling $406.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 8, 2025 involved selling 1,805 shares valued at $200.8K.
Anne Oriordan currently holds 16,500 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anne Oriordan has been a net seller of JAZZ stock. They have purchased $0 and sold $406.7K worth of shares.
Anne Oriordan's most recent insider trade was on Aug 8, 2025, when they sold 1,805 shares at $111.25 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 6, 2024 | JAZZ | $165.2K | Payment | 1,484 | $111.35 | Discretionary |
| Aug 2, 2024 | JAZZ | $0 | Award | 3,731 | $N/A | Discretionary |
| Aug 14, 2023 | JAZZ | $171.5K | Sale | 1,241 | $138.16 | Discretionary |
| Aug 11, 2023 | JAZZ | $0 | Award | 3,075 | $N/A | Discretionary |
| Aug 8, 2022 | JAZZ | $165.9K | Sale | 1,089 | $152.32 | Discretionary |
| Aug 5, 2022 | JAZZ | $0 | Award | 2,561 | $N/A | Discretionary |
| May 9, 2022 | JAZZ | $1.4K | Sale | 9 | $150.49 | Discretionary |
| May 9, 2022 | JAZZ | $68.1K | Sale | 457 | $148.92 | Discretionary |
| Jul 29, 2021 | JAZZ | $0 | Award | 2,246 | $N/A | Discretionary |
| Aug 6, 2020 | JAZZ | $0 | Award | 2,705 | $N/A | Discretionary |
| Aug 8, 2019 | JAZZ | $0 | Award | 1,920 | $N/A | Discretionary |
| Feb 28, 2019 | JAZZ | $0 | Award | 2,840 | $N/A | Discretionary |